Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
fluticasone (cutivate) (1 trial)
COVID-19 convalescent plasma (1 trial)
Inflammation (Phase 4)
Lung Diseases (Phase 4)
Lung Diseases, Obstructive (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Trials (2 total)
Trial APIs (2 total)